411
Views
0
CrossRef citations to date
0
Altmetric
Review Article

MRI brain findings in patients with depression and type 2 diabetes – a scoping review

ORCID Icon, &
Pages 1-7 | Received 06 Mar 2023, Accepted 02 Aug 2023, Published online: 02 Oct 2023

References

  • World Health Organization. Diabetes. Available from: https://www.who.int/health-topics/diabetes#tab=tab_1. Accessed 29 January 2023.
  • Goyal R, Jialal I. Diabetes mellitus type 2. In: Statpearls. Treasure Island, FL: StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513253.
  • Center of Disease Prevention Control. Diabetes. Available from: https://www.cdc.gov/diabetes/managing/mental-health.html. Accessed 29 January 2023.
  • Sartorius N. Depression and diabetes. Dialog Clin Neurosci. 2018;20(1):47–52. https://doi.org/10.31887/DCNS.2018.20.1/nsartorius.
  • Akpalu J, Yorke E, Ainuson-Quampah J, et al. Depression and glycaemic control among type 2 diabetes patients: a cross-sectional study in a tertiary healthcare facility in Ghana. BMC Psych. 2018;18:357. https://doi.org/10.1186/s12888-018-1933-2.
  • Brådvik L. Suicide risk and mental disorders. Int J Environ Res Pub Health. 2018;15(9):2028. https://doi.org/10.3390/ijerph15092028.
  • Orsolini L, Latini R, Pompili M, et al. Understanding the complex of suicide in depression: from research to clinics. Psych Invest. 2020;17(3):207–221. https://doi.org/10.30773/pi.2019.0171.
  • Spillane A, Sikar M, Larkin C, et al. What are the physical and psychological health effects of suicide bereavement on family members? An observational and interview mixed-methods study in Ireland. BMJ Open. 2018;8(1):e019472. https://doi.org/10.1136/bmjopen-2017-019472.
  • National Institute of Aging. How the aging brain affects thinking. Available from: https://www.nia.nih.gov/health/how-aging-brain-affects-thinking#. Accessed 11 February 2023.
  • Fiske A, Wetherell JL, Gatz M. Depression in older adults. Annu Rev Clin Psychol. 2009;5:363–389. https://doi.org/10.1146/annurev.clinpsy.032408.
  • Sheline YI, Sanghavi M, Mintun MA, et al. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci. 1999;19(12):5034–5043.
  • Chopra S, Fornito A, Francey SM, et al. Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: A longitudinal, randomised, triple-blind. Placebo-controlled MRI Study. Neuropsychopharm. 2021;46:1494–1501. https://doi.org/10.1038/s41386-021-00980-0.
  • Li N, Zhou T, Fei E. Actions of metformin in the brain: A New perspective of metformin treatments in related neurological disorders. Int J Mol Sci. 2022;23(15):8281. https://doi.org/10.3390/ijms23158281.
  • Blázquez E, Velázquez E, Hurtado-Carneiro V, et al. Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and Alzheimer’s disease. Front Endocrinol. 2014;5:161. https://doi.org/10.3389/fendo.2014.00161.
  • Zhang F, Peng W, Sweeney JA, et al. Brain structure alterations in depression: psychoradiological evidence. CNS Neurosci Therap. 2018;24(11):994–1003. https://doi.org/10.1111/cns.12835.
  • Trifu SC, Trifu AC, Aluas E, et al. Brain changes in depression. Rom J Morphol Embryol. 2020;61(2):361–370. https://doi.org/10.47162/RJME.61.2.06.
  • George SA, Bruce ML, Silbersweig B, et al. Vascular depression: a new view of late-onset depression. Dialog Clin Neurosci. 1999;1(2):68–80. https://doi.org/10.31887/DCNS.1999.1.2/galexopoulos.
  • Moheet A, Mangia S, Seaquist E. Impact of diabetes on cognitive function and brain structure. Annu NY Acad Sci. 2015;1353:60. https://doi.org/10.1111/nyas.12807.
  • Chen R, Ovbiagele B, Feng W. Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes. Am J Med Sci. 2016;351(4):380. https://doi.org/10.1016/j.amjms.2016.01.011.
  • Towfighi A, Ovbiagele B, El Husseini N, et al. Poststroke depression: A scientific statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2017;48(2):e30–e43. https://doi.org/10.1161/str.0000000000000113.
  • McIntyre RS, Kenna H, Nguyen HT. Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders? Adv Ther. 2010;27(2):63–80. https://doi.org/10.1007/s12325-010-0011–z.
  • Mak S, Thomas A. Steps for conducting a scoping review. J Grad Med Educ. 2022;14(5):565–567. https://doi.org/10.4300/JGME-D-22-00621.1.
  • Brands AMA, Manschot S, Van den Berg E, et al. A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus. J Int Neuropsycholo Soc. 2009: 288–297. https://doi.org/10.1017/s1355617707070312.
  • Ajilore O, Haroon E, Kumaran S, et al. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropsychopharm. 2007;32:1224–1231. https://doi.org/10.1038/sj.npp.1301248.
  • Kumar R, Anstey KJ, Wen W. Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64-year-Old community sample. Am J Geriatr Psych. 2008;16:12. https://doi.org/10.1097/jgp.0b013e31818b40fc.
  • Kumar A, Haroon E, Darwin C, et al. Gray matter prefrontal changes in type 2 diabetes detected using MRI. J Mag Res Imag. 2008;27:14. https://doi.org/10.1002/jmri.21224.
  • Ajilore O, Narr K, Rosenthal J, et al. Regional cortical gray matter thickness differences associated with type 2 diabetes and major depression. Psych Res. 2010;184:63–70. https://doi.org/10.1016/j.pscychresns.2010.07.003.
  • Cui X, Abduljalil A, Manor BD, et al. Multi-Scale glycemic variability: A link to gray matter atrophy and cognitive decline in type 2 diabetes. PLoS ONE. 2014;9(1):e86284. https://doi.org/10.1371/journal.pone.0086284.
  • Hsu F, Yuan M, Bowden DW. Adiposity is inversely associated with hippocampal volume in African Americans and European Americans with diabetes. J Diabetes Compli. 2016;30(8):1506–1512. https://doi.org/10.1016/j.jdiacomp.2016.08.012.
  • Jansen JFA, Van Bussel FCG, van de Haar H, et al. Cerebral blood flow, blood supply, and cognition in type 2 diabetes mellitus. Sci Rep. 2016;6:160003. https://doi.org/10.1038/s41598-016-0003-6.
  • Zhang Q, Zhang P, Yan R, et al. A single-blinded trial using resting-state functional magnetic resonance imaging of brain activityin patients with type 2 diabetes and painful neuropathy. Diabetes Ther. 2019;10:135–147. https://doi.org/10.1007/s13300-018-0534-x.
  • Roy B, Ehlert L, Muller R, et al. Regional brain gray matter changes in patients with type 2 diabetes mellitus. Sci Rep. 2020;10:9925. https://doi.org/10.1038/s41598-020-67022-5.
  • Rensma SP, Sloten TT, Ding J. Type 2 diabetes, change in depressive symptoms over time and cerebral small vessel disease: longitudinal data of the AGES-Reykjavik study. Diabetes Care. 2020;43:1781–1787. https://doi.org/10.2337/dc19-2437.
  • Esplelend AM, Bryan RN, Goveas JS, et al. Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the women’s health initiative magnetic resonance imaging studies. Diabetes Care. 2013;36(1):90–97. https://doi.org/10.2337/dc12-0555.
  • Antal B, McMahon LP, Sultan SF, et al. Type 2 diabetes mellitus accelerates brain aging and cognitive decline: complementary findings from UK biobank and meta-analyses. eLife. 2022;11:e73138. https://doi.org/10.7554/elife.73138.
  • Van Tol MJ, van der Wee NJ, van den Heuvel OA, et al. Regional brain volume in depression and anxiety disorders. Arch Gen Psych. 2010;67(10):1002–1011. https://doi.org/10.1001/archgenpsychiatry.2010.121.
  • Zheng R, Zhang Y, Yang Z, et al. Reduced brain gray matter volume in patients with first-episode major depressive disorder: A quantitative meta-analysis. Front Psych. 2021;12:671348. https://doi.org/10.3389/fpsyt.2021.671348.
  • Espinoza AO, Shaw ME, Alateeq K, et al. Volumetric brain differences in clinical depression in association with anxiety: a systematic review with meta-analysis. J Psych Neurosci. 2020;45(6):406–429. https://doi.org/10.1503/jpn.190156.
  • Guo H, Siu W, D’Arcy RC, et al. MRI assessment of whole-brain structural changes in aging. Clin Interv Aging. 2017;12:1251–1270. https://doi.org/10.147/CIA.S139515.
  • Liao W, Wang Z, Zhang X, et al. Cerebral blood flow changes in remitted early- and late-onset depression patients. Oncotarget. 2017;8(44):76214–76222. https://doi.org/10.18632/oncotarget.19185.
  • Mayor S. Meta-analysis shows difference between antidepressants and placebo is only significant in severe depression. Br Med J. 2008;336:446. https://doi.org/10.1136/bmj.39503.656852.DB.
  • Wei W, Karim HT, Lin C, et al. Trajectories in cerebral blood flow following antidepressant treatment in late-life depression: support for the vascular depression hypothesis. J Clin Psych. 2018;79(6):18m12106. https://doi.org/10.4088/JCP.18m12106.
  • Xu S. Pathogenesis of diabetic cerebral vascular disease complication. World J Diabetes. 2015;6(1):54–66. https://doi.org/10.4239/wjd.v6.i1.54.
  • Bădescu S, Tătaru C, Kobylinska L, et al. The association between diabetes mellitus and depression. J Medicine Life. 2016;9(2):120–125. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863499.
  • Haris M, Cai K, Singh A, et al. In vivo mapping of brain Myo-inositol. NeuroImage. 2011;54(3):2079. https://doi.org/10.1016/j.neuroimage.2010.10.017.
  • DiNicolantonio JJ, H O’Keefe J. Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes. Open Heart. 2022;9:e001989. https://doi.org/10.1136/openhrt-2022-001989.
  • Keks N, Hope J, Keogh S. Switching and stopping antidepressants. Aust Prescr. 2016;39(3):76–83. https://doi.org/10.18773/austprescr.2016.039.
  • Zhuo C, Li G, Lin X, et al. The rise and fall of MRI studies in major depressive disorder. Transl Psych. 2019;9:335. https://doi.org/10.1038/s41398-019-0680-6.